- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.03. | Sona Nanotech Inc.: Sona Presents Additional Preclinical Data Demonstrating Repeated Ability Of Its Cancer Therapy To Inhibit Tumor Growth In Colorectal Cancer Model | 762 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - March 19, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to provide updated data confirming efficacy of its Targeted... ► Artikel lesen | |
| 06.03. | Sona Nanotech Inc. CEO David Regan to Present at the Investor Summit Virtual on March 11 | 393 | ACCESS Newswire | NEW YORK, NY / ACCESS Newswire / March 6, 2025 / David Regan, CEO of Sona Nanotech Inc. (OTCQB:SNANF)(CSE:SONA), will be presenting at this year's Investor Summit Virtual on March 11th at 11:30am ET.About... ► Artikel lesen | |
| 12.02. | Sona Nanotech Inc.: Sona Nanotech's Targeted Hyperthermia Therapy To Be Presented at the International 19th Canadian Melanoma Conference | 429 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - February 12, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that its recently published findings from its... ► Artikel lesen | |
| 14.01. | Sona Nanotech Inc: Sona publishes THT cancer therapy efficacy studies | 1 | Stockwatch | ||
| SONA NANOTECH Aktie jetzt für 0€ handeln | |||||
| 13.01. | Sona Nanotech Inc.: Sona Nanotech's THT Cancer Therapy Preclinical Efficacy Studies Published In Peer-Reviewed Scientific Journal | 461 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - January 13, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that the now complete findings from our previously... ► Artikel lesen | |
| 12.12.24 | Sona Nanotech Inc: Sona releases results from preclinical study of GNRs | 4 | Stockwatch | ||
| 11.12.24 | Sona Nanotech Inc.: Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study | 545 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - December 11, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") announces results from its most recent preclinical study of its Targeted... ► Artikel lesen | |
| 07.11.24 | Sona Nanotech Inc.: Sona Nanotech to Showcase Its THT Cancer Therapy at NCL 20th Anniversary Symposium and Provides Corporate Update | 538 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - November 7, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that its Chief Scientific Officer, Dr. Len Pagliaro... ► Artikel lesen | |
| 21.10.24 | Sona Nanotech Inc.: Sona Nanotech Issued Patent and Appoints New Board Member | 559 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 21, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce the issuance of U.S. Patent No. 12117447 by... ► Artikel lesen | |
| 09.10.24 | Sona Nanotech Inc.: Sona Nanotech Grants Options | 565 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 9, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that it has granted 25,000 incentive stock... ► Artikel lesen | |
| 24.09.24 | Sona Nanotech Inc.: Sona Nanotech Closes Private Placement Financing to Raise $1,643,750 in Gross Proceeds | 754 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - September 24, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that it has closed its non-brokered private... ► Artikel lesen | |
| 05.09.24 | Sona Nanotech Inc.: Sona Nanotech Closes Private Placement Financing to Raise $1,500,000 in Gross Proceeds and Announces Additional Financing | 851 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - September 5, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that it has closed its non-brokered private... ► Artikel lesen | |
| 31.07.24 | Sona Nanotech Inc.: Sona Nanotech to Arrange Private Placement Financing | 722 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - July 31, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that it plans to raise up to $1,500,000 through... ► Artikel lesen | |
| 26.06.24 | Sona Nanotech Inc.: Sona's Cancer Therapy Triggers Abscopal Effect, Eliminating Distant Tumors In Preclinical Melanoma Study | 753 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - June 26, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that a detailed biomarker analysis of the recently... ► Artikel lesen | |
| 20.06.24 | Sona Nanotech Inc.: Sona's Therapy Shows Significant Preclinical Efficacy in Second Cancer | 755 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - June 20, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that its targeted hyperthermia therapy ("THT")... ► Artikel lesen | |
| 21.05.24 | Sona Nanotech Inc.: Sona Appoints Chief Medical Officer and Files Provisional Conjugation Patent | 822 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - May 21, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to advise that it has appointed Dr. Carman Giacomantonio MD... ► Artikel lesen | |
| 29.04.24 | Sona Nanotech Inc.: Sona's Cancer Therapy Creates a Systemic Immune Response in Murine Breast Cancer Model | 877 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - April 29, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") announces further results from the triple negative breast cancer murine... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 23,050 | +1,32 % | Aktienmarkt: Formycon-Aktie kann sich nicht behaupten (22,45 €) | Im Minus liegt aktuell die Aktie von Formycon . Zuletzt zahlten Investoren für das Papier 22,45 Euro. Ein Minus in Höhe von 60 Cent müssen derzeit die Aktionäre von Formycon hinnehmen. Die Aktie wird... ► Artikel lesen | |
| OBDUCAT | 0,053 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025 | Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY... ► Artikel lesen | |
| SOLESENCE | 2,510 | -0,79 % | Solésence, Inc.: Solésence Announces Uplisting to Nasdaq | Trading set to begin Tuesday, April 8 under new ticker "SLSN" ROMEOVILLE, Ill., April 07, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions... ► Artikel lesen | |
| ONTO INNOVATION | 110,00 | -0,90 % | EQS-Media: LPKF Laser & Electronics SE: Onto Innovation und LPKF treiben gemeinsam die Massenproduktion von Glassubstraten für Halbleiter voran | EQS-Media / 02.04.2025 / 09:00 CET/CEST
Onto Innovation und LPKF treiben gemeinsam die Massenproduktion von Glassubstraten für Halbleiter voran
LPKF schließt sich dem Packaging Applications... ► Artikel lesen | |
| VEECO INSTRUMENTS | 17,100 | 0,00 % | Veeco Instruments Inc.: Veeco Updates Fourth Quarter and Full Year 2024 Guidance | PLAINVIEW, N.Y., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (NASDAQ: VECO) today has updated its financial guidance for the fourth quarter and full year 2024. We expect revenue for... ► Artikel lesen | |
| KOPIN | 1,019 | -3,23 % | Kopin Wins U.S. Army Contract To Define MicroLED Standards For XR Warfighter Displays | WASHINGTON (dpa-AFX) - Kopin Corporation (KOPN), a specialist in high-performance microdisplays and optical systems, Thursday announced that it has secured a significant contract with the U.S.... ► Artikel lesen | |
| ZENTEK | 1,150 | +3,60 % | Zentek Ltd.: Zentek Provides Update on ~$1.1 Million Innovative Solutions Canada Contract to Develop an Avian Influenza Countermeasure Using its Multivalent Aptamer Technology | GUELPH, ON / ACCESS Newswire / April 23, 2025 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), is pleased to announce that it has completed the first phase of the Innovative Solutions... ► Artikel lesen | |
| NVE | 50,50 | -1,94 % | NVE Corporation (NVEC): Among Most Expensive Stocks Insiders Are Buying After Trump's Tariff Rollout | ||
| XTPL | 23,000 | +2,45 % | EQS-News: XTPL S.A.: XTPL posts its highest-ever sales in Q4 2024 with growth prospects for 2025 | Issuer: XTPL S.A.
/ Key word(s): Preliminary Results/Sales Result
XTPL posts its highest-ever sales in Q4 2024 with growth prospects for 2025
22.01.2025 / 09:13 CET/CEST
The... ► Artikel lesen | |
| DOTZ NANO | 0,041 | 0,00 % | XFRA 57N: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ACACIA RESEARCH | 2,800 | +9,38 % | Acacia Research Reports Third Quarter 2024 Financial Results | NEW YORK--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG) ("Acacia" or the "Company"), which acquires and operates businesses across the industrial, energy and technology sectors, today... ► Artikel lesen | |
| GAUZY | 10,220 | +0,89 % | Gauzy in Reverse Despite Mercedes-Benz Link | ||
| CANATU | 12,000 | +4,35 % | Canatu Oyj: Inside information: Canatu signs joint development agreement with DENSO to improve carbon nanotube performance | Canatu Plc Inside Information 14 April 2025 at 1:00 pm EEST
Inside information: Canatu signs joint development agreement with DENSO to improve carbon nanotube performance
Canatu Plc (CANATU, Nasdaq... ► Artikel lesen | |
| LEHNER INVESTMENTS | 0,033 | +1,56 % | EQS-Adhoc: LEHNER INVESTMENTS AG: Sonderprüfung gerichtlich angeordnet | EQS-Ad-hoc: LEHNER INVESTMENTS AG / Schlagwort(e): Rechtssache
LEHNER INVESTMENTS AG: Sonderprüfung gerichtlich angeordnet
04.04.2025 / 18:00 CET/CEST
Veröffentlichung einer Insiderinformation... ► Artikel lesen | |
| ADVANCE ZINCTEK | 0,404 | +1,00 % | ADVANCE ZINCTEK LIMITED: Business Update |
SONA NANOTECH INC gehört der Branche Nanotechnologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SONA NANOTECH INC finden Sie auf Wallstreet Online.
